| pubmed-article:19001114 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19001114 | lifeskim:mentions | umls-concept:C0020205 | lld:lifeskim |
| pubmed-article:19001114 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
| pubmed-article:19001114 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
| pubmed-article:19001114 | lifeskim:mentions | umls-concept:C0808080 | lld:lifeskim |
| pubmed-article:19001114 | lifeskim:mentions | umls-concept:C0205345 | lld:lifeskim |
| pubmed-article:19001114 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
| pubmed-article:19001114 | lifeskim:mentions | umls-concept:C1135882 | lld:lifeskim |
| pubmed-article:19001114 | lifeskim:mentions | umls-concept:C0442821 | lld:lifeskim |
| pubmed-article:19001114 | lifeskim:mentions | umls-concept:C1705922 | lld:lifeskim |
| pubmed-article:19001114 | lifeskim:mentions | umls-concept:C0453882 | lld:lifeskim |
| pubmed-article:19001114 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19001114 | pubmed:dateCreated | 2008-12-25 | lld:pubmed |
| pubmed-article:19001114 | pubmed:abstractText | The relative strengths of the uncommon promoters hybrid 2, hybrid 1 with an active P2 promoter (hybrid 1+P2), and strong+P2, which drive transcription of resistance genes in class 1 integrons, were evaluated using bla(GES-1) as a reporter gene cassette. Hybrid 2 was stronger than hybrid 1. Coupling P2 with the strong promoter and with hybrid 1 caused a measurable increase in GES-1 expression. | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19001114 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19001114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19001114 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19001114 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19001114 | pubmed:issn | 1098-6596 | lld:pubmed |
| pubmed-article:19001114 | pubmed:author | pubmed-author:MiriagouViviV | lld:pubmed |
| pubmed-article:19001114 | pubmed:author | pubmed-author:TzouvelekisLe... | lld:pubmed |
| pubmed-article:19001114 | pubmed:author | pubmed-author:Papagiannitsi... | lld:pubmed |
| pubmed-article:19001114 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19001114 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:19001114 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19001114 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19001114 | pubmed:pagination | 277-80 | lld:pubmed |
| pubmed-article:19001114 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:19001114 | pubmed:meshHeading | pubmed-meshheading:19001114... | lld:pubmed |
| pubmed-article:19001114 | pubmed:meshHeading | pubmed-meshheading:19001114... | lld:pubmed |
| pubmed-article:19001114 | pubmed:meshHeading | pubmed-meshheading:19001114... | lld:pubmed |
| pubmed-article:19001114 | pubmed:meshHeading | pubmed-meshheading:19001114... | lld:pubmed |
| pubmed-article:19001114 | pubmed:meshHeading | pubmed-meshheading:19001114... | lld:pubmed |
| pubmed-article:19001114 | pubmed:meshHeading | pubmed-meshheading:19001114... | lld:pubmed |
| pubmed-article:19001114 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19001114 | pubmed:articleTitle | Relative strengths of the class 1 integron promoter hybrid 2 and the combinations of strong and hybrid 1 with an active p2 promoter. | lld:pubmed |
| pubmed-article:19001114 | pubmed:affiliation | Laboratory of Bacteriology, Hellenic Pasteur Institute, Athens, Greece. | lld:pubmed |
| pubmed-article:19001114 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19001114 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19001114 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19001114 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19001114 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19001114 | lld:pubmed |
